nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—CYP2C9—Capecitabine—esophageal cancer	0.165	0.326	CbGbCtD
Prasugrel—CYP2B6—Cisplatin—esophageal cancer	0.157	0.311	CbGbCtD
Prasugrel—ALB—Methotrexate—esophageal cancer	0.1	0.198	CbGbCtD
Prasugrel—CYP2C9—Cisplatin—esophageal cancer	0.0832	0.164	CbGbCtD
Prasugrel—Haematochezia—Capecitabine—esophageal cancer	0.00387	0.0466	CcSEcCtD
Prasugrel—Clopidogrel—ABCB1—esophageal cancer	0.00384	1	CrCbGaD
Prasugrel—Pericardial effusion—Capecitabine—esophageal cancer	0.00379	0.0458	CcSEcCtD
Prasugrel—Pericardial effusion—Methotrexate—esophageal cancer	0.00282	0.0341	CcSEcCtD
Prasugrel—Haematoma—Capecitabine—esophageal cancer	0.00248	0.0299	CcSEcCtD
Prasugrel—Haemoptysis—Capecitabine—esophageal cancer	0.0021	0.0254	CcSEcCtD
Prasugrel—Body temperature increased—Carboplatin—esophageal cancer	0.00203	0.0245	CcSEcCtD
Prasugrel—Contusion—Capecitabine—esophageal cancer	0.00178	0.0215	CcSEcCtD
Prasugrel—Rectal haemorrhage—Capecitabine—esophageal cancer	0.00172	0.0208	CcSEcCtD
Prasugrel—Cerebrovascular accident—Cisplatin—esophageal cancer	0.00156	0.0189	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.00153	0.0185	CcSEcCtD
Prasugrel—Ecchymosis—Capecitabine—esophageal cancer	0.00141	0.017	CcSEcCtD
Prasugrel—Neoplasm—Capecitabine—esophageal cancer	0.00141	0.017	CcSEcCtD
Prasugrel—Atrial fibrillation—Capecitabine—esophageal cancer	0.00119	0.0144	CcSEcCtD
Prasugrel—Cerebrovascular accident—Capecitabine—esophageal cancer	0.00115	0.0139	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.00113	0.0136	CcSEcCtD
Prasugrel—Pain in extremity—Capecitabine—esophageal cancer	0.00113	0.0136	CcSEcCtD
Prasugrel—Bradycardia—Cisplatin—esophageal cancer	0.00108	0.013	CcSEcCtD
Prasugrel—Ecchymosis—Methotrexate—esophageal cancer	0.00105	0.0126	CcSEcCtD
Prasugrel—Neoplasm—Methotrexate—esophageal cancer	0.00105	0.0126	CcSEcCtD
Prasugrel—Urinary tract disorder—Cisplatin—esophageal cancer	0.00105	0.0126	CcSEcCtD
Prasugrel—Urethral disorder—Cisplatin—esophageal cancer	0.00104	0.0125	CcSEcCtD
Prasugrel—Eye disorder—Cisplatin—esophageal cancer	0.000991	0.012	CcSEcCtD
Prasugrel—Immune system disorder—Cisplatin—esophageal cancer	0.000958	0.0116	CcSEcCtD
Prasugrel—Mediastinal disorder—Cisplatin—esophageal cancer	0.000956	0.0115	CcSEcCtD
Prasugrel—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000859	0.0104	CcSEcCtD
Prasugrel—Anaemia—Cisplatin—esophageal cancer	0.000853	0.0103	CcSEcCtD
Prasugrel—Haematuria—Capecitabine—esophageal cancer	0.00083	0.01	CcSEcCtD
Prasugrel—Leukopenia—Cisplatin—esophageal cancer	0.000826	0.00997	CcSEcCtD
Prasugrel—Epistaxis—Capecitabine—esophageal cancer	0.000821	0.00991	CcSEcCtD
Prasugrel—Bradycardia—Capecitabine—esophageal cancer	0.000796	0.00961	CcSEcCtD
Prasugrel—Haemoglobin—Capecitabine—esophageal cancer	0.000786	0.00948	CcSEcCtD
Prasugrel—Haemorrhage—Capecitabine—esophageal cancer	0.000782	0.00944	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000781	0.00942	CcSEcCtD
Prasugrel—Urinary tract disorder—Capecitabine—esophageal cancer	0.000772	0.00932	CcSEcCtD
Prasugrel—Oedema peripheral—Capecitabine—esophageal cancer	0.00077	0.00929	CcSEcCtD
Prasugrel—Urethral disorder—Capecitabine—esophageal cancer	0.000766	0.00925	CcSEcCtD
Prasugrel—Anaphylactic shock—Cisplatin—esophageal cancer	0.000754	0.00909	CcSEcCtD
Prasugrel—Thrombocytopenia—Cisplatin—esophageal cancer	0.000738	0.0089	CcSEcCtD
Prasugrel—Skin disorder—Cisplatin—esophageal cancer	0.000732	0.00883	CcSEcCtD
Prasugrel—Eye disorder—Capecitabine—esophageal cancer	0.000731	0.00882	CcSEcCtD
Prasugrel—Angiopathy—Capecitabine—esophageal cancer	0.000709	0.00856	CcSEcCtD
Prasugrel—Immune system disorder—Capecitabine—esophageal cancer	0.000706	0.00852	CcSEcCtD
Prasugrel—Mediastinal disorder—Capecitabine—esophageal cancer	0.000705	0.0085	CcSEcCtD
Prasugrel—Hypotension—Cisplatin—esophageal cancer	0.000704	0.0085	CcSEcCtD
Prasugrel—Dyspnoea—Cisplatin—esophageal cancer	0.000672	0.00811	CcSEcCtD
Prasugrel—Back pain—Capecitabine—esophageal cancer	0.000658	0.00794	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000651	0.00785	CcSEcCtD
Prasugrel—P2RY12—epithelium—esophageal cancer	0.000641	0.192	CbGeAlD
Prasugrel—Anaemia—Capecitabine—esophageal cancer	0.000629	0.00759	CcSEcCtD
Prasugrel—Haematuria—Methotrexate—esophageal cancer	0.000618	0.00746	CcSEcCtD
Prasugrel—Epistaxis—Methotrexate—esophageal cancer	0.000612	0.00738	CcSEcCtD
Prasugrel—Leukopenia—Capecitabine—esophageal cancer	0.000609	0.00735	CcSEcCtD
Prasugrel—Body temperature increased—Cisplatin—esophageal cancer	0.000596	0.00719	CcSEcCtD
Prasugrel—Cough—Capecitabine—esophageal cancer	0.000594	0.00717	CcSEcCtD
Prasugrel—Hypertension—Capecitabine—esophageal cancer	0.000588	0.00709	CcSEcCtD
Prasugrel—Haemoglobin—Methotrexate—esophageal cancer	0.000585	0.00706	CcSEcCtD
Prasugrel—Haemorrhage—Methotrexate—esophageal cancer	0.000582	0.00702	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000575	0.00694	CcSEcCtD
Prasugrel—Urinary tract disorder—Methotrexate—esophageal cancer	0.000575	0.00694	CcSEcCtD
Prasugrel—Urethral disorder—Methotrexate—esophageal cancer	0.000571	0.00689	CcSEcCtD
Prasugrel—Hypersensitivity—Cisplatin—esophageal cancer	0.000555	0.0067	CcSEcCtD
Prasugrel—Eye disorder—Methotrexate—esophageal cancer	0.000544	0.00656	CcSEcCtD
Prasugrel—Thrombocytopenia—Capecitabine—esophageal cancer	0.000544	0.00656	CcSEcCtD
Prasugrel—Asthenia—Cisplatin—esophageal cancer	0.000541	0.00652	CcSEcCtD
Prasugrel—Skin disorder—Capecitabine—esophageal cancer	0.00054	0.00651	CcSEcCtD
Prasugrel—Angiopathy—Methotrexate—esophageal cancer	0.000528	0.00637	CcSEcCtD
Prasugrel—Immune system disorder—Methotrexate—esophageal cancer	0.000526	0.00634	CcSEcCtD
Prasugrel—Mediastinal disorder—Methotrexate—esophageal cancer	0.000525	0.00633	CcSEcCtD
Prasugrel—Hypotension—Capecitabine—esophageal cancer	0.000519	0.00626	CcSEcCtD
Prasugrel—Diarrhoea—Cisplatin—esophageal cancer	0.000516	0.00622	CcSEcCtD
Prasugrel—Dyspnoea—Capecitabine—esophageal cancer	0.000495	0.00598	CcSEcCtD
Prasugrel—Back pain—Methotrexate—esophageal cancer	0.00049	0.00591	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00048	0.00579	CcSEcCtD
Prasugrel—Fatigue—Capecitabine—esophageal cancer	0.000479	0.00578	CcSEcCtD
Prasugrel—Rash—Cisplatin—esophageal cancer	0.000475	0.00573	CcSEcCtD
Prasugrel—Dermatitis—Cisplatin—esophageal cancer	0.000475	0.00573	CcSEcCtD
Prasugrel—Anaemia—Methotrexate—esophageal cancer	0.000468	0.00565	CcSEcCtD
Prasugrel—Leukopenia—Methotrexate—esophageal cancer	0.000454	0.00547	CcSEcCtD
Prasugrel—Nausea—Cisplatin—esophageal cancer	0.000448	0.0054	CcSEcCtD
Prasugrel—Cough—Methotrexate—esophageal cancer	0.000442	0.00534	CcSEcCtD
Prasugrel—Body temperature increased—Capecitabine—esophageal cancer	0.000439	0.0053	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000428	0.00517	CcSEcCtD
Prasugrel—Anaphylactic shock—Methotrexate—esophageal cancer	0.000413	0.00499	CcSEcCtD
Prasugrel—Hypersensitivity—Capecitabine—esophageal cancer	0.000409	0.00494	CcSEcCtD
Prasugrel—Thrombocytopenia—Methotrexate—esophageal cancer	0.000405	0.00489	CcSEcCtD
Prasugrel—CES2—bronchus—esophageal cancer	0.000403	0.121	CbGeAlD
Prasugrel—Skin disorder—Methotrexate—esophageal cancer	0.000402	0.00485	CcSEcCtD
Prasugrel—Asthenia—Capecitabine—esophageal cancer	0.000399	0.00481	CcSEcCtD
Prasugrel—CES2—smooth muscle tissue—esophageal cancer	0.000394	0.118	CbGeAlD
Prasugrel—Hypotension—Methotrexate—esophageal cancer	0.000386	0.00466	CcSEcCtD
Prasugrel—Diarrhoea—Capecitabine—esophageal cancer	0.00038	0.00459	CcSEcCtD
Prasugrel—Dyspnoea—Methotrexate—esophageal cancer	0.000369	0.00445	CcSEcCtD
Prasugrel—Dizziness—Capecitabine—esophageal cancer	0.000367	0.00443	CcSEcCtD
Prasugrel—CES2—trachea—esophageal cancer	0.000361	0.108	CbGeAlD
Prasugrel—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000357	0.00431	CcSEcCtD
Prasugrel—Fatigue—Methotrexate—esophageal cancer	0.000356	0.0043	CcSEcCtD
Prasugrel—Rash—Capecitabine—esophageal cancer	0.00035	0.00423	CcSEcCtD
Prasugrel—Dermatitis—Capecitabine—esophageal cancer	0.00035	0.00422	CcSEcCtD
Prasugrel—Headache—Capecitabine—esophageal cancer	0.000348	0.0042	CcSEcCtD
Prasugrel—Nausea—Capecitabine—esophageal cancer	0.00033	0.00398	CcSEcCtD
Prasugrel—Body temperature increased—Methotrexate—esophageal cancer	0.000327	0.00394	CcSEcCtD
Prasugrel—CES2—digestive system—esophageal cancer	0.000311	0.0931	CbGeAlD
Prasugrel—Hypersensitivity—Methotrexate—esophageal cancer	0.000305	0.00368	CcSEcCtD
Prasugrel—Asthenia—Methotrexate—esophageal cancer	0.000297	0.00358	CcSEcCtD
Prasugrel—Diarrhoea—Methotrexate—esophageal cancer	0.000283	0.00341	CcSEcCtD
Prasugrel—Dizziness—Methotrexate—esophageal cancer	0.000273	0.0033	CcSEcCtD
Prasugrel—Rash—Methotrexate—esophageal cancer	0.000261	0.00315	CcSEcCtD
Prasugrel—Dermatitis—Methotrexate—esophageal cancer	0.00026	0.00314	CcSEcCtD
Prasugrel—CES2—lung—esophageal cancer	0.00026	0.0778	CbGeAlD
Prasugrel—Headache—Methotrexate—esophageal cancer	0.000259	0.00313	CcSEcCtD
Prasugrel—Nausea—Methotrexate—esophageal cancer	0.000246	0.00296	CcSEcCtD
Prasugrel—ALB—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000222	0.000549	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000222	0.000549	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CTNNA1—esophageal cancer	0.000213	0.000528	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CXCL2—esophageal cancer	0.000212	0.000525	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000211	0.000523	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000201	0.000498	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000199	0.000492	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PSME2—esophageal cancer	0.000198	0.000491	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PSME1—esophageal cancer	0.000198	0.000491	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—ANXA1—esophageal cancer	0.000197	0.000488	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000193	0.000479	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—SST—esophageal cancer	0.000192	0.000475	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—EP300—esophageal cancer	0.000189	0.000468	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000188	0.000467	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—CFL1—esophageal cancer	0.000187	0.000463	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—GHRL—esophageal cancer	0.000187	0.000463	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NOTCH3—esophageal cancer	0.000187	0.000463	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—FBXW7—esophageal cancer	0.000184	0.000455	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—BLVRB—esophageal cancer	0.000178	0.000441	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—SLC52A3—esophageal cancer	0.000178	0.000441	CbGpPWpGaD
Prasugrel—CES2—lymph node—esophageal cancer	0.000178	0.0532	CbGeAlD
Prasugrel—ALB—Hemostasis—GNG7—esophageal cancer	0.000176	0.000436	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000174	0.00043	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—TP53—esophageal cancer	0.000171	0.000424	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000169	0.000418	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000168	0.000416	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NOTCH2—esophageal cancer	0.000168	0.000415	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.00016	0.000397	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000158	0.000392	CbGpPWpGaD
Prasugrel—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000158	0.000391	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000153	0.000378	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000152	0.000375	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—SLC10A2—esophageal cancer	0.000151	0.000375	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CA1—esophageal cancer	0.000151	0.000375	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000151	0.000373	CbGpPWpGaD
Prasugrel—ALB—Metabolism—SLC52A3—esophageal cancer	0.00015	0.000371	CbGpPWpGaD
Prasugrel—ALB—Metabolism—BLVRB—esophageal cancer	0.00015	0.000371	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TGFBR2—esophageal cancer	0.000149	0.000368	CbGpPWpGaD
Prasugrel—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000149	0.000368	CbGpPWpGaD
Prasugrel—CYP2B6—bronchus—esophageal cancer	0.000145	0.0435	CbGeAlD
Prasugrel—ALB—Hemostasis—HSPA5—esophageal cancer	0.000144	0.000356	CbGpPWpGaD
Prasugrel—CYP2C19—digestive system—esophageal cancer	0.000143	0.0429	CbGeAlD
Prasugrel—P2RY12—Signaling Pathways—SMAD4—esophageal cancer	0.000141	0.000349	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—PIK3CA—esophageal cancer	0.00014	0.000346	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CA2—esophageal cancer	0.000139	0.000343	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000138	0.000342	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—TP53—esophageal cancer	0.000135	0.000335	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—BLVRB—esophageal cancer	0.000135	0.000333	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SLC52A3—esophageal cancer	0.000135	0.000333	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000134	0.000332	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PLCE1—esophageal cancer	0.000129	0.000319	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ADH7—esophageal cancer	0.000129	0.000319	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CA1—esophageal cancer	0.000128	0.000316	CbGpPWpGaD
Prasugrel—ALB—Metabolism—SLC10A2—esophageal cancer	0.000128	0.000316	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SLC52A3—esophageal cancer	0.000123	0.000304	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—BLVRB—esophageal cancer	0.000123	0.000304	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.00012	0.000298	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CA2—esophageal cancer	0.000117	0.000289	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—HIF1A—esophageal cancer	0.000115	0.000285	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SLC10A2—esophageal cancer	0.000114	0.000283	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CA1—esophageal cancer	0.000114	0.000283	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000114	0.000282	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ADH1B—esophageal cancer	0.000113	0.00028	CbGpPWpGaD
Prasugrel—CYP2B6—digestive system—esophageal cancer	0.000112	0.0336	CbGeAlD
Prasugrel—CYP2C9—digestive system—esophageal cancer	0.000111	0.0333	CbGeAlD
Prasugrel—P2RY12—Signaling Pathways—KDR—esophageal cancer	0.00011	0.000273	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.00011	0.000272	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PLCE1—esophageal cancer	0.000108	0.000268	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ADH7—esophageal cancer	0.000108	0.000268	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—TYMP—esophageal cancer	0.000108	0.000267	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000107	0.000265	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—ABL1—esophageal cancer	0.000106	0.000264	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP26A1—esophageal cancer	0.000105	0.00026	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CA2—esophageal cancer	0.000105	0.000259	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CA1—esophageal cancer	0.000104	0.000258	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SLC10A2—esophageal cancer	0.000104	0.000258	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NOTCH1—esophageal cancer	0.000104	0.000257	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000102	0.000253	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ALOX15—esophageal cancer	0.000102	0.000253	CbGpPWpGaD
Prasugrel—ALB—lymph node—esophageal cancer	0.000102	0.0304	CbGeAlD
Prasugrel—CYP2B6—Metabolism—GSTO1—esophageal cancer	9.76e-05	0.000242	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—TPI1—esophageal cancer	9.76e-05	0.000242	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ADH7—esophageal cancer	9.73e-05	0.000241	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PLCE1—esophageal cancer	9.73e-05	0.000241	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	9.62e-05	0.000238	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CA2—esophageal cancer	9.55e-05	0.000236	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ADH1B—esophageal cancer	9.51e-05	0.000235	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CREBBP—esophageal cancer	9.41e-05	0.000233	CbGpPWpGaD
Prasugrel—CYP2B6—lung—esophageal cancer	9.37e-05	0.0281	CbGeAlD
Prasugrel—CYP2B6—Metabolism—ALDOB—esophageal cancer	9.36e-05	0.000232	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	9.33e-05	0.000231	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	9.3e-05	0.00023	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—EGFR—esophageal cancer	9.25e-05	0.000229	CbGpPWpGaD
Prasugrel—ALB—Metabolism—TYMP—esophageal cancer	9.09e-05	0.000225	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GAPDH—esophageal cancer	9.01e-05	0.000223	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CRABP1—esophageal cancer	8.93e-05	0.000221	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	8.93e-05	0.000221	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PLCE1—esophageal cancer	8.88e-05	0.00022	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ADH7—esophageal cancer	8.88e-05	0.00022	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—PIK3CA—esophageal cancer	8.84e-05	0.000219	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP26A1—esophageal cancer	8.84e-05	0.000219	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	8.77e-05	0.000217	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ALOX15—esophageal cancer	8.61e-05	0.000213	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ADH1B—esophageal cancer	8.54e-05	0.000211	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GNG7—esophageal cancer	8.49e-05	0.00021	CbGpPWpGaD
Prasugrel—CYP3A4—digestive system—esophageal cancer	8.47e-05	0.0254	CbGeAlD
Prasugrel—P2RY12—Signaling Pathways—NOS3—esophageal cancer	8.43e-05	0.000209	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTO1—esophageal cancer	8.22e-05	0.000203	CbGpPWpGaD
Prasugrel—ALB—Metabolism—TPI1—esophageal cancer	8.22e-05	0.000203	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—TYMP—esophageal cancer	8.16e-05	0.000202	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SLC52A3—esophageal cancer	8.1e-05	0.0002	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—BLVRB—esophageal cancer	8.1e-05	0.0002	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—PIK3CA—esophageal cancer	8.03e-05	0.000199	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ALDH2—esophageal cancer	7.96e-05	0.000197	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP26A1—esophageal cancer	7.94e-05	0.000196	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—ERBB2—esophageal cancer	7.88e-05	0.000195	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ALDOB—esophageal cancer	7.88e-05	0.000195	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ADH1B—esophageal cancer	7.78e-05	0.000193	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ALOX15—esophageal cancer	7.73e-05	0.000191	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—NOS2—esophageal cancer	7.68e-05	0.00019	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GAPDH—esophageal cancer	7.58e-05	0.000188	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GSTT1—esophageal cancer	7.57e-05	0.000187	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CRABP1—esophageal cancer	7.52e-05	0.000186	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP2A6—esophageal cancer	7.48e-05	0.000185	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—TYMP—esophageal cancer	7.44e-05	0.000184	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTO1—esophageal cancer	7.38e-05	0.000183	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—TPI1—esophageal cancer	7.38e-05	0.000183	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP26A1—esophageal cancer	7.24e-05	0.000179	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GNG7—esophageal cancer	7.15e-05	0.000177	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ENO1—esophageal cancer	7.09e-05	0.000176	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PTGS1—esophageal cancer	7.09e-05	0.000176	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ALDOB—esophageal cancer	7.07e-05	0.000175	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ALOX15—esophageal cancer	7.05e-05	0.000175	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PSME1—esophageal cancer	6.99e-05	0.000173	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PSME2—esophageal cancer	6.99e-05	0.000173	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CCND1—esophageal cancer	6.96e-05	0.000172	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—CREBBP—esophageal cancer	6.89e-05	0.000171	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CA1—esophageal cancer	6.88e-05	0.00017	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SLC10A2—esophageal cancer	6.88e-05	0.00017	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GAPDH—esophageal cancer	6.81e-05	0.000169	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CRABP1—esophageal cancer	6.75e-05	0.000167	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CDKN1A—esophageal cancer	6.74e-05	0.000167	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	6.74e-05	0.000167	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTO1—esophageal cancer	6.73e-05	0.000166	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—TPI1—esophageal cancer	6.73e-05	0.000166	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ALDH2—esophageal cancer	6.7e-05	0.000166	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ALDOB—esophageal cancer	6.45e-05	0.00016	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GNG7—esophageal cancer	6.42e-05	0.000159	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—EP300—esophageal cancer	6.41e-05	0.000159	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTT1—esophageal cancer	6.37e-05	0.000158	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP2A6—esophageal cancer	6.3e-05	0.000156	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CA2—esophageal cancer	6.3e-05	0.000156	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	6.27e-05	0.000155	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GAPDH—esophageal cancer	6.21e-05	0.000154	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—NOS3—esophageal cancer	6.17e-05	0.000153	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CRABP1—esophageal cancer	6.15e-05	0.000152	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP1B1—esophageal cancer	6.03e-05	0.000149	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ALDH2—esophageal cancer	6.01e-05	0.000149	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PTGS1—esophageal cancer	5.97e-05	0.000148	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ENO1—esophageal cancer	5.97e-05	0.000148	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.97e-05	0.000148	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PSME2—esophageal cancer	5.88e-05	0.000146	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PSME1—esophageal cancer	5.88e-05	0.000146	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PLCE1—esophageal cancer	5.85e-05	0.000145	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ADH7—esophageal cancer	5.85e-05	0.000145	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GNG7—esophageal cancer	5.85e-05	0.000145	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTT1—esophageal cancer	5.72e-05	0.000142	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP19A1—esophageal cancer	5.67e-05	0.00014	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP2A6—esophageal cancer	5.65e-05	0.00014	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.63e-05	0.000139	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MYC—esophageal cancer	5.59e-05	0.000138	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ALDH2—esophageal cancer	5.48e-05	0.000136	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—EGFR—esophageal cancer	5.46e-05	0.000135	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PTGS1—esophageal cancer	5.36e-05	0.000133	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ENO1—esophageal cancer	5.36e-05	0.000133	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PSME2—esophageal cancer	5.28e-05	0.000131	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PSME1—esophageal cancer	5.28e-05	0.000131	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTT1—esophageal cancer	5.22e-05	0.000129	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—HMOX1—esophageal cancer	5.17e-05	0.000128	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP2A6—esophageal cancer	5.16e-05	0.000128	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.14e-05	0.000127	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.14e-05	0.000127	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ADH1B—esophageal cancer	5.13e-05	0.000127	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP1B1—esophageal cancer	5.08e-05	0.000126	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ABCB1—esophageal cancer	4.97e-05	0.000123	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—TYMP—esophageal cancer	4.91e-05	0.000121	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ENO1—esophageal cancer	4.89e-05	0.000121	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PTGS1—esophageal cancer	4.89e-05	0.000121	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PSME2—esophageal cancer	4.82e-05	0.000119	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PSME1—esophageal cancer	4.82e-05	0.000119	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP19A1—esophageal cancer	4.77e-05	0.000118	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP26A1—esophageal cancer	4.77e-05	0.000118	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PIK3CA—esophageal cancer	4.74e-05	0.000117	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—EP300—esophageal cancer	4.69e-05	0.000116	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ALOX15—esophageal cancer	4.65e-05	0.000115	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.61e-05	0.000114	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TP53—esophageal cancer	4.59e-05	0.000114	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP1B1—esophageal cancer	4.56e-05	0.000113	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—TPI1—esophageal cancer	4.44e-05	0.00011	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTO1—esophageal cancer	4.44e-05	0.00011	CbGpPWpGaD
Prasugrel—ALB—Metabolism—HMOX1—esophageal cancer	4.36e-05	0.000108	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP19A1—esophageal cancer	4.29e-05	0.000106	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.27e-05	0.000106	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ALDOB—esophageal cancer	4.25e-05	0.000105	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.21e-05	0.000104	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ABCB1—esophageal cancer	4.18e-05	0.000103	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP1B1—esophageal cancer	4.16e-05	0.000103	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GAPDH—esophageal cancer	4.09e-05	0.000101	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CRABP1—esophageal cancer	4.06e-05	0.0001	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—HMOX1—esophageal cancer	3.91e-05	9.68e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP19A1—esophageal cancer	3.91e-05	9.67e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GNG7—esophageal cancer	3.86e-05	9.55e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.84e-05	9.49e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ABCB1—esophageal cancer	3.75e-05	9.29e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ALDH2—esophageal cancer	3.62e-05	8.95e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—HMOX1—esophageal cancer	3.57e-05	8.83e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.5e-05	8.66e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CA—esophageal cancer	3.47e-05	8.59e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTT1—esophageal cancer	3.44e-05	8.51e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ABCB1—esophageal cancer	3.42e-05	8.47e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP2A6—esophageal cancer	3.4e-05	8.42e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TP53—esophageal cancer	3.36e-05	8.31e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CREBBP—esophageal cancer	3.32e-05	8.22e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PTGS1—esophageal cancer	3.22e-05	7.98e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ENO1—esophageal cancer	3.22e-05	7.98e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PSME1—esophageal cancer	3.18e-05	7.86e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PSME2—esophageal cancer	3.18e-05	7.86e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.16e-05	7.82e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—NOS3—esophageal cancer	2.97e-05	7.36e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.84e-05	7.02e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CREBBP—esophageal cancer	2.79e-05	6.92e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP1B1—esophageal cancer	2.74e-05	6.78e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PTGS2—esophageal cancer	2.72e-05	6.73e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.59e-05	6.4e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP19A1—esophageal cancer	2.58e-05	6.38e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CREBBP—esophageal cancer	2.51e-05	6.21e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—NOS3—esophageal cancer	2.5e-05	6.19e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HMOX1—esophageal cancer	2.35e-05	5.82e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PTGS2—esophageal cancer	2.29e-05	5.66e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CREBBP—esophageal cancer	2.29e-05	5.66e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—EP300—esophageal cancer	2.26e-05	5.6e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.26e-05	5.59e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—NOS3—esophageal cancer	2.25e-05	5.56e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PTGS2—esophageal cancer	2.05e-05	5.08e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—NOS3—esophageal cancer	2.05e-05	5.07e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—EP300—esophageal cancer	1.9e-05	4.71e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PTGS2—esophageal cancer	1.87e-05	4.64e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—EP300—esophageal cancer	1.71e-05	4.23e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CA—esophageal cancer	1.67e-05	4.14e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—EP300—esophageal cancer	1.56e-05	3.86e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.51e-05	3.73e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CA—esophageal cancer	1.41e-05	3.48e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—NOS3—esophageal cancer	1.35e-05	3.34e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CA—esophageal cancer	1.26e-05	3.13e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.24e-05	3.06e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.15e-05	2.85e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—EP300—esophageal cancer	1.03e-05	2.54e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CA—esophageal cancer	7.6e-06	1.88e-05	CbGpPWpGaD
